Trial Profile
The Effect of Dolutegravir-based ART on Serum Etonogestrel Levels in HIV-infected Women Using Contraceptive Implants in Botswana
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Efavirenz (Primary) ; Etonogestrel (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- 06 May 2020 Results published in the Contraception
- 04 Feb 2020 Status changed from recruiting to completed.
- 29 Aug 2019 Planned End Date changed from 1 Sep 2019 to 1 Mar 2020.